Citigroup’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18
| Closed | -$272 | – | 5119 |
|
|
2022
Q4 | $272 | Sell |
18
-54
| -75% | -$816 | ﹤0.01% | 4770 |
|
|
2022
Q3 | $0 | Buy |
+72
| New | – | ﹤0.01% | 5671 |
|
|
2022
Q2 | – | Sell |
-83
| Closed | -$3K | – | 5935 |
|
|
2022
Q1 | $3K | Buy |
+83
| New | +$3K | ﹤0.01% | 5188 |
|
|
2021
Q3 | – | Sell |
-3
| Closed | – | – | 5624 |
|
|
2021
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 5723 |
|
|
2021
Q1 | – | Sell |
-11
| Closed | -$1K | – | 5633 |
|
|
2020
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 5166 |
|
|
2020
Q3 | $1K | Sell |
11
-18
| -62% | -$1.64K | ﹤0.01% | 5004 |
|
|
2020
Q2 | $2K | Sell |
29
-198
| -87% | -$13.7K | ﹤0.01% | 4954 |
|
|
2020
Q1 | $26K | Sell |
227
-179
| -44% | -$20.5K | ﹤0.01% | 4228 |
|
|
2019
Q4 | $100K | Buy |
406
+143
| +54% | +$35.2K | ﹤0.01% | 3548 |
|
|
2019
Q3 | $90K | Sell |
263
-1,153
| -81% | -$395K | ﹤0.01% | 3505 |
|
|
2019
Q2 | $1.3M | Buy |
1,416
+1,193
| +535% | +$1.1M | ﹤0.01% | 1946 |
|
|
2019
Q1 | $356K | Sell |
223
-1,407
| -86% | -$2.25M | ﹤0.01% | 2736 |
|
|
2018
Q4 | $3.05M | Buy |
1,630
+1,397
| +600% | +$2.61M | ﹤0.01% | 1296 |
|
|
2018
Q3 | $549K | Buy |
233
+114
| +96% | +$269K | ﹤0.01% | 2454 |
|
|
2018
Q2 | $410K | Buy |
119
+108
| +982% | +$372K | ﹤0.01% | 2486 |
|
|
2018
Q1 | $32K | Buy |
11
+4
| +57% | +$11.6K | ﹤0.01% | 4002 |
|
|
2017
Q4 | $18K | Sell |
7
-591
| -99% | -$1.52M | ﹤0.01% | 4292 |
|
|
2017
Q3 | $1.7M | Sell |
598
-418
| -41% | -$1.19M | ﹤0.01% | 1598 |
|
|
2017
Q2 | $2.4M | Buy |
1,016
+510
| +101% | +$1.21M | ﹤0.01% | 1369 |
|
|
2017
Q1 | $1.27M | Sell |
506
-982
| -66% | -$2.47M | ﹤0.01% | 1749 |
|
|
2016
Q4 | $3.36M | Buy |
1,488
+1,139
| +326% | +$2.57M | ﹤0.01% | 1373 |
|
|
2016
Q3 | $874K | Buy |
349
+209
| +149% | +$523K | ﹤0.01% | 2036 |
|
|
2016
Q2 | $427K | Sell |
140
-122
| -47% | -$372K | ﹤0.01% | 2347 |
|
|
2016
Q1 | $833K | Buy |
262
+226
| +628% | +$719K | ﹤0.01% | 2227 |
|
|
2015
Q4 | $188K | Sell |
36
-110
| -75% | -$574K | ﹤0.01% | 3107 |
|
|
2015
Q3 | $465K | Buy |
146
+103
| +240% | +$328K | ﹤0.01% | 2253 |
|
|
2015
Q2 | $171K | Sell |
43
-2
| -4% | -$7.95K | ﹤0.01% | 2851 |
|
|
2015
Q1 | $180K | Sell |
45
-51
| -53% | -$204K | ﹤0.01% | 3034 |
|
|
2014
Q4 | $470K | Buy |
96
+9
| +10% | +$44.1K | ﹤0.01% | 2500 |
|
|
2014
Q3 | $354K | Sell |
87
-34
| -28% | -$138K | ﹤0.01% | 2247 |
|
|
2014
Q2 | $489K | Buy |
121
+66
| +120% | +$267K | ﹤0.01% | 2009 |
|
|
2014
Q1 | $248K | Sell |
55
-73
| -57% | -$329K | ﹤0.01% | 2685 |
|
|
2013
Q4 | $447K | Buy |
128
+61
| +91% | +$213K | ﹤0.01% | 2449 |
|
|
2013
Q3 | $277K | Buy |
67
+49
| +272% | +$203K | ﹤0.01% | 2361 |
|
|
2013
Q2 | $71K | Buy |
+18
| New | +$71K | ﹤0.01% | 3541 |
|